After After
Before Before

10115 - Rodent, Nasal MCM, AB-PAS

INTRODUCTION
Nasal mucous cell metaplasia (MCM) is a remodeling process where nasal respiratory epithelial cells undergo metaplasia to mucous cells. This causes an increased production of mucous, which leads to increased airway obstruction. Mucous cell metaplasia is often observed as a feature of allergic airways disease after exposure to an allergen. The mucosubstances in the respiratory epithelium are identified by staining with Alcian Blue (pH 2.5)/Periodic Acid-Schiff (AB/PAS or AB-PAS). Using this APP the degree of mucous cell metaplasia is quantified in the nasal respiratory epithelium as the volume of mucosubstances per length of basal lamina. 

KEYWORDS
Mucous cell metaplasia, nose, nasal, respiratory, AB/PAS, AB-PAS, airway disease, quantitative, image analysis.

METHODS
The first image processing step takes place inside the manually outlined general region of interest (ROI), and involves the segmentation of the tissue into epithelial tissue and remaining tissue as shown in figure 3. Secondly, the basal lamina is identified as the border between the epithelial tissue and the remaining tissue, see figure 5. Afterwards the intraepithelial mucosubstances are identified based on a linear Bayesian classification combined with prior knowledge of the size of mucusubstances, see Figure 5. Finally, relevant output parameters such as the basal lamina length and the mucous area are quantified.

QUANTITATIVE OUTPUT VARIABLES
The output variables obtained from this protocol are:

  • Basal Lamina Length: The length of basal lamina inside all ROI’s
  • Epithelial Tissue Area: The area of epithelial tissue inside all ROI’s
  • Mucous area: The area of mucous inside all ROI’s
  • Mucous per Basal Lamina: Mucous area / Basal Lamina Length. Quantification of MCM defined as the ratio of mucous area relative to the basal lamina length. 
  • Mucous per Epithelial Tissue: Mucous area / Epithelial Tissue Area
  • Epithelial Tissue per Basal Lamina: Epithelial Tissue Area / Basal Lamina Length
     

AUXILIARY APPS (included) 
APP: "01 Tissue detect"
APP: "03 Analyze"

WORKFLOW
Step 1: Manually outline the nasal cavity as the region of interest, see figure 2.
Step 2: Load the APP for tissue detection “01 Tissue Detect” which outlines the background, epithelial tissue and remaining tissue.
Step 3: Load the APP for mucous detection “02 Mucous Detect” which identifies the basal lamina and mucosubstances inside the epithelial tissue.  
Step 4: Load the quantification protocol “03 Analyze” which quantifies the relevant output parameters. Click the save button to transfer the results to the database.

STAINING PROTOCOL
The staining protocol has not been specified.

ADDITIONAL INFORMATION
The APP utilizes the Visiopharm EngineTM and Viewer software modules, where EngineTM offers an execution platform to expand processing capability and speed of image analysis. The Viewer gives a fast review together with several types of image adjustment properties ex. outlining of regions, annotations and direct measures of distance, curve length, radius, etc. 
By adding the AuthorTM module the APP can be customized to fit other purposes. AuthorTM offers a comprehensive and dedicated set of tools for creating new fit-for-purpose analysis APPs, and no programming experience is required.

REFERENCES
There are currently no references.

 

RUO
FIGURE 1
FIGURE 1
Cross section of rodent head, stained with AB/PAS.
FIGURE 2
FIGURE 2
Close-up on nasal cavity with manually outlined region of interest.
FIGURE 3
FIGURE 3
Results of analysis with the APP: "01 Tissue Detect". The background, epithelial tissue and the remaining tissue are outlined.
FIGURE 4
FIGURE 4
Close up of nasal epithelium.
FIGURE 5
FIGURE 5
Results of analysis with the APP: "02 Mucous Detect". The bright blue label identifies the basal lamina, and the dark blue label identifies the intraepithelial mucosubstances. The bright pink label denotes the epithelial tissue, and the dark pink denotes the remaining tissue.